Security key
82835W108
ARS Pharmaceuticals, Inc. - Common Stock (SPRY)
CUSIP: 82835W108
Q3 2023 13F Holders as of 30 Sep 2023
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 66,524,840
- Total 13F value
- $251,464,826
- Share change
- +11,453,795
- Put/Call ratio
- 42%
- SEC-reported price per share
- $3.78
- Number of holders
- 94
- Value change
- +$38,754,815
- Number of buys
- 59
- Number of sells
- 40
- Shares outstanding
- 98,457,811
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2023
Institutions
94
Top holders
10
SPRY full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
ARS Pharmaceuticals, Inc. SEC filings
ARS Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 82835W108
Recent filing periods:
Ownership snapshot
Top reported holders of SPRY - ARS Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
DEERFIELD MANAGEMENT COMP...
Disclosed value leader
DEERFIELD MANAGEMENT COMP...
Comparable rows
15/15
Latest evidence
30 Jun 2023
13F
Lead comparable stake: 11%
Showing 1-6 of 15 holder rows.
Quick read
DEERFIELD MANAGEMENT COMPANY, L.P. leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens DEERFIELD MANAGEMENT COMPANY, L.P.'s linked filing trail.
Comparable ownership
Top 5
DEERFIELD MANAGEMENT COMPANY, L.P.
11%
ORBIMED ADVISORS LLC
8.9%
FMR LLC
4.7%
SR ONE CAPITAL MANAGEMENT, LP
4.1%
RA CAPITAL MANAGEMENT, L.P.
3.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
Company
|
11%
|
$74,222,111
11,077,927 shares
|
— | 30 Jun 2023 |
| ORBIMED ADVISORS LLC |
13F
Company
|
8.9%
|
$58,563,943
8,740,887 shares
|
— | 30 Jun 2023 |
| FMR LLC |
13F
Company
|
4.7%
|
$31,254,014
4,664,778 shares
|
— | 30 Jun 2023 |
| SR ONE CAPITAL MANAGEMENT, LP |
13F
Company
|
4.1%
|
$26,886,450
4,012,903 shares
|
— | 30 Jun 2023 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
3.1%
|
$20,164,843
3,009,678 shares
|
— | 30 Jun 2023 |
| Rubric Capital Management LP |
13F
Company
|
2.8%
|
$18,754,660
2,799,203 shares
|
— | 30 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
94
Shares
66,524,840
Rows available
94
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
92
Q3 2023 holders
94
Holder diff
2
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 value | Q3 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend